Eco R1 Capital, LLC Portfolio Holdings

Eco R1 Capital, LLC

  • $2.83 Billion
  • Q2 2024

Eco R1 Capital, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $2.83 Billion distributed in 55 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $445M, Prothena Corp Public LTD CO with a value of $239M, Sarepta Therapeutics, Inc. with a value of $222M, Crinetics Pharmaceuticals, Inc. with a value of $186M, and Arvinas, Inc. with a value of $179M.

Examining the 13F form we can see an decrease of $677M in the current position value, from $3.51B to 2.83B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.83 Billion
Healthcare: $2.83 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.13B
$445 Million 15.74% of portfolio
11,607,425
Q2 2024 Added 2.2%
$1.04B
$239 Million 8.45% of portfolio
11,584,280
Q1 2022 Added 2.66%
$10.9B
$222 Million 7.86% of portfolio
1,407,322
Q2 2024 Reduced 26.7%
$2.89B
$186 Million 6.58% of portfolio
4,155,375
Q1 2024 Added 106.48%
$1.33B
$179 Million 6.33% of portfolio
6,726,491
Q4 2023 Added 23.04%
$2.19B
$170 Million 6.0% of portfolio
4,982,945
Q2 2024 Added 108.98%
$1.99B
$143 Million 5.04% of portfolio
5,756,268
Q2 2023 Added 35.61%
$1.4B
$120 Million 4.23% of portfolio
5,806,871
Q2 2023 Reduced 12.53%
$925M
$114 Million 4.04% of portfolio
13,330,736
Q4 2023 Added 52.85%
$6.82B
$108 Million 3.82% of portfolio
1,013,952
Q4 2023 Added 175.22%
$1.28B
$101 Million 3.57% of portfolio
5,330,416
Q1 2024 Added 0.91%
$3.82B
$75 Million 2.65% of portfolio
1,389,276
Q1 2024 New
$2.08B
$61.6 Million 2.18% of portfolio
1,469,818
Q2 2024 New
$663M
$56.1 Million 1.98% of portfolio
19,209,643
Q3 2023 Added 38.23%
$1.6B
$51.6 Million 1.82% of portfolio
5,714,404
Q2 2024 Added 1.7%
$594M
$48.2 Million 1.7% of portfolio
3,249,835
Q2 2024 Added 62.55%
$547M
$41.4 Million 1.46% of portfolio
3,182,444
Q4 2023 Added 6.71%
$205M
$38.9 Million 1.38% of portfolio
19,364,688
Q3 2023 New
$242M
$31 Million 1.1% of portfolio
3,917,546
Q1 2024 Added 1.71%
$2.17B
$30.9 Million 1.09% of portfolio
757,576
Q1 2024 New
$107M
$29.3 Million 1.03% of portfolio
5,000,000
Q2 2023 New
$181M
$26.9 Million 0.95% of portfolio
27,404,070
Q1 2024 New
$391M
$24.2 Million 0.85% of portfolio
3,418,068
Q1 2022 Reduced 1.47%
$2.07B
$24.1 Million 0.85% of portfolio
650,000
Q1 2024 New
$1.19B
$22.5 Million 0.8% of portfolio
1,250,385
Q1 2024 Reduced 64.21%
$6.88B
$22.7 Million 0.8% of portfolio
300,000
Q1 2024 New
$2.64B
$21.9 Million 0.77% of portfolio
1,346,475
Q2 2024 Reduced 77.53%
$4.14B
$21 Million 0.74% of portfolio
75,000
Q1 2024 New
$802M
$18.4 Million 0.65% of portfolio
910,000
Q2 2024 New
$322M
$18 Million 0.64% of portfolio
5,441,896
Q2 2024 Reduced 11.45%
$706M
$16.9 Million 0.6% of portfolio
900,000
Q4 2023 New
$1.76B
$15.1 Million 0.53% of portfolio
427,039
Q1 2024 New
$1.49B
$10.9 Million 0.39% of portfolio
508,393
Q2 2024 New
$1.47B
$8.57 Million 0.3% of portfolio
187,500
Q1 2024 New
$69.8M
$8.13 Million 0.29% of portfolio
11,294,585
Q1 2024 New
$549M
$7.65 Million 0.27% of portfolio
850,341
Q2 2024 New
$330M
$6.1 Million 0.22% of portfolio
1,250,000
Q4 2023 New
$153M
$5.77 Million 0.2% of portfolio
2,046,867
Q2 2023 Added 4.61%
$391M
$3.6 Million 0.13% of portfolio
700,000
Q1 2024 New
$260M
$3.37 Million 0.12% of portfolio
5,717,324
Q2 2024 Added 24.42%
$133M
$3.39 Million 0.12% of portfolio
2,042,771
Q2 2024 Reduced 29.18%
$581M
$2.24 Million 0.08% of portfolio
6,389,468
Q4 2023 Added 61.83%
Atara Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q2 2021 Added 5.17%
$0
$1,000 0.0% of portfolio
100,000
Q2 2021 New
-
$0 0.0% of portfolio
-
Q1 2021 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$0
$1,000 0.0% of portfolio
66,665
Q3 2021 New

Summary

  • Portfolio
  • No. of Stocks 55
  • Current Value $2.83 Billion
  • Prior Value $3.51 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 7 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email